clinical trial · NCT07368569
A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body
Boehringer Ingelheim·phase1·completed·n = 14
HealthyMetformin hydrochlorideBI 764198
brief summary
The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
started
Feb 6, 2026
primary completion
Mar 14, 2026
completion
Mar 17, 2026
last updated
Apr 14, 2026
official title
Investigation of the Effect of BI 764198 on the Pharmacokinetics of Metformin Following Multiple Oral Administration in Healthy Male and Female Trial Participants (an Open-label, Randomised, Two-way Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol